Silhouette Instalift has released an unaudited trading update for the six months that ended on 30 June. Sales for the period were £23.3m ($30.9) versus £20.1m for the same period in 2017 equating to 6% headline growth. The company stated that performance of the group contributed £20.5m, delivering an encouraging 16.5% growth equivalent to 18% on a constant currency basis. The new sales force in the US for Sinclair Pharma generated £800,000 of revenue.
Sinclair Pharma has released an unaudited trading update for the six months that ended on 30 June. Sales for the period were £23.3m ($30.9) versus £20.1m for the same period in 2017 equating to 6% headline growth. The company stated that performance of the group contributed £20.5m, delivering an encouraging 16.5% growth equivalent to 18% on a constant currency basis. The new sales force in the US for Silhouette Instalift generated £800,000 of revenue.